Industry Focus
Healthcare: GW Pharma Poised for First FDA Marijuana Approval
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:36
- Mas informaciones
Informações:
Sinopsis
Promo: GW Pharmaceuticals scores a big thumbs up from a panel of FDA experts for its marijuana-based drug. Plus, Biogen pays a $1 billion dollars for expanded access to Ionis’ novel pipeline.